Plain-English translation of NCT03394417 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether StrataXRT, a silicone-based gel, can better prevent severe radiation skin damage than the standard creams usually prescribed during head and neck cancer treatment. About half of patients receiving radiation and chemotherapy together develop painful, damaging skin reactions. This study compares the new gel to standard cream to see if it provides better protection.
Radiation skin damage is a common and serious side effect that causes pain, reduces quality of life, and can delay cancer treatment. Doctors currently use many different creams and lotions, but there's no clear evidence that one works better than another, so this study aims to find a better solution.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either the new silicone gel or standard cream and apply your assigned product to your skin during radiation treatment. You'll have your skin checked weekly during treatment, once the week after treatment ends, and then every week for up to 6 weeks after treatment finishes. The study team will photograph and evaluate your skin at each visit to see how well the treatment prevented skin damage.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Singapore